# clm_747F97C3BEDC

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 1,663,496,000 United States dollar  
valid_from: 2018-09-30  
valid_to: 2019-03-31  
published: 2018-11-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_47864C915D20  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 1,663,496,000 United States dollar", as of 2018-09-30 (until 2019-03-31). Claim clm_747F97C3BEDC, https://asof.is/claim/clm_747F97C3BEDC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2018, filed 2018-11-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217618000036/0001532176-18-000036-index.htm (primary, SEC EDGAR 10-Q Q3 FY2018, published 2018-11-06)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 1,608,022,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_747F97C3BEDC](/claim/clm_747F97C3BEDC.md) | [clm_31D8E26EE368](/claim/clm_31D8E26EE368.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.